Zimmer Biomet Holdings (XSWX:ZBH) Short-Term Debt: CHF926 Mil (As of Mar. 2026)


XSWX:ZBH Zimmer Biomet Holdings Inc XSWX:ZBH
72 GF Score
Price CHF73.50
GF Value CHF101.61
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings Short-Term Debt?

Zimmer Biomet Holdings XSWX:ZBH +2.80% 72 Short-Term Debt is CHF926 Mil as of Mar. 2026. GuruFocus rates XSWX:ZBH with a GF Score™ of 72/100 and a GF Value™ of CHF101.61. The stock has 3 warning signs investors should review.

Zimmer Biomet Holdings's Short-Term Debt for the quarter that ended in Mar. 2026 was CHF926 Mil.

Zimmer Biomet Holdings's quarterly Short-Term Debt declined from Sep. 2025 (CHF478 Mil) to Dec. 2025 (CHF468 Mil) but then increased from Dec. 2025 (CHF468 Mil) to Mar. 2026 (CHF926 Mil).

Zimmer Biomet Holdings's annual Short-Term Debt declined from Dec. 2023 (CHF778 Mil) to Dec. 2024 (CHF769 Mil) and declined from Dec. 2024 (CHF769 Mil) to Dec. 2025 (CHF468 Mil).

Zimmer Biomet Holdings Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Zimmer Biomet Holdings Short-Term Debt Related Terms

Zimmer Biomet Holdings Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Zimmer Biomet Holdings's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings Short-Term Debt Chart

Zimmer Biomet Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,478.30 507.07 778.32 769.45 467.86

Zimmer Biomet Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 530.16 666.82 477.66 467.86 925.79
XSWX:ZBH
72GF Score
Zimmer Biomet Holdings Inc XSWX:ZBH
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of CHF926 Mil mean?
Zimmer Biomet Holdings (XSWX:ZBH) has a Short-Term Debt of CHF926 Mil as of Mar. 2026.
Is Zimmer Biomet Holdings' Short-Term Debt too high?
Zimmer Biomet Holdings' current Short-Term Debt is CHF926 Mil. Overall, Zimmer Biomet Holdings has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Short-Term Debt compare to STE and PEN?
Zimmer Biomet Holdings' Short-Term Debt of CHF926 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Zimmer Biomet Holdings's current Short-Term Debt is CHF926 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Zimmer Biomet Holdings (XSWX:ZBH) has a current Short-Term Debt of CHF926 Mil. The stock's GF Value™ is CHF101.61, compared to a current price of CHF73.50 — trading 27.7% below its estimated fair value. The current Short-Term Debt is CHF926 Mil. Zimmer Biomet Holdings' overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Short-Term Debt is CHF926 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF73.50 is trading 27.7% below its estimated GF Value™ of CHF101.61.

Key valuation signals for XSWX:ZBH:

  • Short-Term Debt: CHF926 Mil
  • GF Value™: CHF101.61 vs. price of CHF73.50 (27.7% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
72GF Score

Get the complete analysis for XSWX:ZBH

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF73.50
Price
CHF101.61
GF Value